First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study
Our real-life study showed that a four-drug induction therapy containing DARA does not impact transplant safety outcomes.
Authors
- Mercedes Gori (ORCID: https://orcid.org/0000-0003-0081-3549)
- Iolanda Donatella Vincelli (ORCID: https://orcid.org/0000-0002-9768-698X)
- Violetta Marafioti
- Maria Caterina Micò (ORCID: https://orcid.org/0009-0006-6931-4632)
- Barbara Loteta (ORCID: https://orcid.org/0009-0001-1406-422X)
- Martina Pitea (ORCID: https://orcid.org/0000-0002-3982-4141)
- Maria Pellicano
- Gaetana Porto (ORCID: https://orcid.org/0000-0003-4739-349X)
- Graziella D’Arrigo (ORCID: https://orcid.org/0000-0003-1831-7340)
- Giuseppe Lazzaro
- Massimo Vincenzo Martino (ORCID: https://orcid.org/0000-0002-3987-419X)
- Annalisa Pitino (ORCID: https://orcid.org/0000-0002-7768-3925)
- Ilaria Maria Delfino (ORCID: https://orcid.org/0000-0002-1597-1913)
- Giovanna Utano
- Francesca Cogliandro
- Giovanni Luigi Tripepi
- Annalisa Sgarlata
- Aurora Idato
- Giorgia Policastro (ORCID: https://orcid.org/0009-0008-5857-7247)
- Caterina Alati
- Anna Scopelliti
- Giovanni Leanza
Institutions
- Azienda ospedaliera "Bianchi-Melacrino-Morelli" (IT)
- Istituto di Fisiologia Clinica (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3390/cancers16193307
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45